Applied immunohistochemistry & molecular morphology : AIMM
Journal
Overview
publication venue for
-
Cytomegalovirus-associated pulmonary septal capillary injury sine inclusion body change: a distinctive cause of occult or macroscopic pulmonary hemorrhage in the immunocompetent host.
2005
-
Cutaneous immunocytoma: a clinical, histologic, and phenotypic study of 11 cases.
2004
-
A Standardization Protocol for the In Situ Detection of SARS-CoV2 RNA and Proteins..
30.
2022
-
Expression Analysis of GD2 by Immunohistochemistry in Invasive Breast Carcinoma: Clinical and Pathologic Correlation..
30.
2022
-
A Subset of Intrahepatic Cholangiocarcinomas Express Albumin RNA as Detected by In Situ Hybridization..
29.
2021
-
Identification of Immunohistochemical Reagents for In Situ Protein Expression Analysis of Coronavirus-associated Changes in Human Tissues..
29.
2021
-
Does Simian Virus 40 (SV40) Have a Role in UK Malignant Pleural Mesothelioma? No Role is Identified in a Sensitive RNA In Situ Hybridization Study on Potentially Affected Birth Cohorts..
28.
2020
-
Expression of the Receptor for Hyaluronic Acid-Mediated Motility (RHAMM) in Endometrial Cancer is Associated With Adverse Histologic Parameters and Tumor Progression..
28.
2020
-
Lymphoid Enhancer Binding Factor 1 (LEF1) and Paired Box Gene 8 (PAX8): A Limited Immunohistochemistry Panel to Distinguish Solid Pseudopapillary Neoplasms and Pancreatic Neuroendocrine Tumors..
28.
2020
-
Immunohistochemical Detection of γ/δ T Lymphocytes in Formalin-fixed Paraffin-embedded Tissues..
27.
2019
-
Automated RNA In Situ Hybridization for 18 High Risk Human Papilloma Viruses in Squamous Cell Carcinoma of the Head and Neck: Comparison With p16 Immunohistochemistry..
27.
2019
-
RNA In Situ Hybridization for Epstein-Barr Virus and Cytomegalovirus: Comparison With In Situ Hybridization and Immunohistochemistry..
27.
2019
-
Utility of Stathmin-1 as a Novel Marker in Evaluating Anal Intraepithelial Neoplasia (AIN)..
27.
2019
-
Comparison of β-Catenin and LEF1 Immunohistochemical Stains in Desmoid-type Fibromatosis and its Selected Mimickers, With Unexpected Finding of LEF1 Positivity in Scars..
26.
2018
-
Diagnostic Utility of PD-L1 Expression in Lung Adenocarcinoma: Immunohistochemistry and RNA In Situ Hybridization..
26.
2018
-
Pulmonary Adenocarcinoma With Enteric Differentiation: Immunohistochemistry and Molecular Morphology..
26.
2018
-
Parafibromin, APC, and MIB-1 Are Useful Markers for Distinguishing Parathyroid Carcinomas From Adenomas..
25.
2017
-
Viral-induced Modulation of Multiple Checkpoint Proteins in Cancers..
25.
2017
-
Prostate-specific Membrane Antigen (PSMA) Expression in the Neovasculature of Gynecologic Malignancies: Implications for PSMA-targeted Therapy..
25.
2017
-
Modulation of PD-L1 and CD8 Activity in Idiopathic and Infectious Chronic Inflammatory Conditions..
25.
2017
-
GNAS Mutations in Fibrous Dysplasia: A Comparative Study of Standard Sequencing and Locked Nucleic Acid PCR Sequencing on Decalcified and Nondecalcified Formalin-fixed Paraffin-embedded Tissues..
24.
2016
-
Image-guided Coring for Large-scale Studies in Molecular Pathology..
24.
2016
-
Her2 and Ki67 Biomarkers Predict Recurrence of Ductal Carcinoma in Situ..
24.
2016
-
PIK3CA Mutations are Common in Many Tumor Types and are Often Associated With Other Driver Mutations..
24.
2016
-
Expression of the chemokine receptor gene, CCR8, is associated With DUSP22 rearrangements in anaplastic large cell lymphoma..
23.
2015
-
Requisite analytic and diagnostic performance characteristics for the clinical detection of BRAF V600E in hairy cell leukemia: a comparison of 2 allele-specific PCR assays..
23.
2015
-
The role of immunohistochemical analysis in the evaluation of EML4-ALK gene rearrangement in lung cancer..
23.
2015
-
BRAF mutations in metastatic malignant melanoma: comparison of molecular analysis and immunohistochemical expression..
22.
2014
-
Automated in situ hybridization for human papilloma virus..
22.
2014
-
Immunohistochemical Investigation of BRAF p.V600E mutations in thyroid carcinoma using 2 separate BRAF antibodies..
22.
2014
-
In search of the ideal immunopanel to distinguish metastatic mammary carcinoma from primary lung carcinoma: a tissue microarray study of 207 cases..
22.
2014
-
Melan A (A103) is not a marker of mesothelioma..
21.
2013
-
A new immunohistochemical ER/PR image analysis system: a multisite performance study..
19.
2011
-
Reading immunohistochemical slides on a computer monitor--a multisite performance study using 180 HER2-stained breast carcinomas..
19.
2011
-
PAX-2 expression in non-neoplastic, primary neoplastic, and metastatic neoplastic tissue: A comprehensive immunohistochemical study..
18.
2010
-
Protocol for PTEN expression by immunohistochemistry in formalin-fixed paraffin-embedded human breast carcinoma..
18.
2010
-
The role of cytotoxic and regulatory T cells in relapsed/refractory Hodgkin lymphoma..
18.
2010
-
Potential role of tissue microarrays for the study of biomarker expression in benign breast disease and normal breast tissue..
17.
2009
-
p16 immunohistochemistry as an alternative marker to distinguish atypical lipomatous tumor from deep-seated lipoma..
17.
2009
-
NY-BR-1 is a differentiation antigen of the mammary gland..
15.
2007
-
Reduced CD1d expression in colonic epithelium in microscopic colitis..
14.
2006
-
Autoimmune-like pulmonary disease in association with parvovirus B19: a clinical, morphologic, and molecular study of 12 cases..
14.
2006
-
Primary cutaneous CD30+ large cell B-cell lymphoma: a series of 10 cases..
14.
2006
-
Safety and biologic activity of intravenous BCL-2 antisense oligonucleotide (G3139) and taxane chemotherapy in patients with advanced cancer..
13.
2005
-
Assessment of T-cell clonality via T-cell receptor-gamma rearrangements in cutaneous T-cell-dominant infiltrates using polymerase chain reaction and single-stranded DNA conformational polymorphism assay..
12.
2004
-
Differential expression patterns of c-REL protein in classic and nodular lymphocyte predominant Hodgkin lymphoma..
12.
2004
-
Immunophenotypic and genotypic characterization of progression in follicular lymphomas..
12.
2004
-
Melan-A (A103) and inhibin expression in ovarian neoplasms..
11.
2003
-
p27 and cyclin E/D2 associations in testicular germ cell tumors: implications for tumorigenesis..
11.
2003
-
MUC-1 mucin protein expression in B-cell lymphomas..
11.
2003
-
Expression of p27 and VHL in renal tumors..
10.
2002
-
Immunohistochemical and reverse transcription-polymerase chain reaction expression analysis of tyrosinase and microphthalmia-associated transcription factor in angiomyolipomas..
9.
2001
-
Immunohistochemistry cocktails are here to stay: Center of Medicare and Medicaid Services should revise its new reimbursement policy..
20.
2012
Identity
ISO Abbreviation
-
Appl Immunohistochem Mol Morphol
Linking ISSN
International Standard Serial Number (ISSN)
Electronic International Standard Serial Number (EISSN)